Besides a first snapshot of Activin-A induced changes in the TME of a solid cancer at single-cell resolution, these findings provide proof of principle that the associated immune evasion and tumor growth can be mitigated by targeting a novel interaction with the STING pathway. Here, STING1 is linked to neoplasm.